Literature DB >> 8971438

Improved tolerability of ritonavir derived from pharmacokinetic principles.

C Merry, M Barry, S Gibbons, F Mulcahy, D Back.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8971438      PMCID： PMC2042721          DOI： 10.1046/j.1365-2125.1996.d01-3339.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  3 in total

Review 1.  The role of therapeutic drug monitoring in treatment of HIV infection.

Authors:  D J Back; S H Khoo; S E Gibbons; C Merry
Journal:  Br J Clin Pharmacol       Date:  2001-04       Impact factor: 4.335

2.  Toxicities Associated With Metformin/Ritonavir Combination Treatment in Relapsed/Refractory Multiple Myeloma.

Authors:  Nitya Nathwani; Joycelynne Palmer; Timothy W Synold; Behrouz Salehian; Michael Rosenzweig; James F Sanchez; Samantha N Hammond; Kehinde Adekola; Valeria Tomarchio; Arnab Chowdhury; Chatchada Karanes; Myo Htut; Firoozeh Sahebi; Tanya Siddiqi; Amrita Krishnan; Stephen J Forman; Steven T Rosen
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2020-05-29

3.  The pharmacokinetic interaction between ivacaftor and ritonavir in healthy volunteers.

Authors:  Anne Marie Liddy; Gavin McLaughlin; Susanne Schmitz; Deirdre M D'Arcy; Michael G Barry
Journal:  Br J Clin Pharmacol       Date:  2017-06-27       Impact factor: 4.335
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.